Atlas Venture
Atlas Venture builds breakthrough biotechnology companies, partnering with leading life science entrepreneurs to translate groundbreaking science into life-changing medicines. With over 30 years of experience, they have a strong track record of launching startups and achieving successful exits.
United States)AAVantgarde Bio, Accent Therapeutics, Actelion, Adnexus Therapeutics, Aerovate Therapeutics, Affinia Therapeutics, Aiolos Bio, Akero Therapeutics, Alnylam Pharmaceuticals, Annovation Biopharma, Arkuda Therapeutics, ArQule, Arteaus Therapeutics, Avila Therapeutics, Be Biopharma, Bicycle Therapeutics, Cadent Therapeutics, Cogent Biosciences, Comanche Biopharma, CoStim Pharmaceuticals, Crucell, Day One Biopharmaceuticals, deCODE genetics, Delinia, Diagonal Therapeutics, Disarm Therapeutics, Disc Medicine, Dyne Therapeutics, Exelixis, F-Star Alpha Limited, Generation Bio, GRObio, Harbour Antibodies, Horizon Pharma, HotSpot Therapeutics, IFM Therapeutics, Ikena Oncology, Intellia Therapeutics, Judo Bio, K36 Therapeutics, Kailera Therapeutics, Kinaset Therapeutics, Korro Bio, Kymera Therapeutics, Lifordi Immunotherapeutics, Lysosomal Therapeutics, Inc., Mariana Oncology, Matchpoint Therapeutics, Micromet, Momenta Pharmaceuticals, MorphoSys, nChroma Bio, Nimbus Therapeutics, Novexel, Obsidian Therapeutics, Padlock Therapeutics, Pheon Therapeutics, Q32 Bio, Rectify, Remix Therapeutics, Replimune, Rodin Therapeutics, Scorpion Therapeutics, Sionna Therapeutics, Spero Therapeutics, Stromedix, Surface Oncology, Synlogic, Third Harmonic Bio, Trace Neuroscience, Translate Bio, TRIANA Biomedicines, Triveni Bio, Vedere Bio, Versanis Bio, Vigil Neuroscience, Vitae Pharmaceuticals, Xilio Therapeutics